Two drugs with separate records
Tesamorelin vs Sermorelin: what can studies truly compare?
Tesamorelin and sermorelin send the same kind of order. You'll see how their makeup differs and why studies can't name a winner.
What is the basic tesamorelin vs sermorelin difference?
Tesamorelin and sermorelin are man-made drugs that ask the growth gland to release hormone. This tesamorelin vs sermorelin page compares their parts and the proof for each.
Both copy a brain hormone. Tesamorelin contains all 44 amino acids, the small parts that join to form that hormone. Its first part is changed so the body breaks the drug down more slowly.
Sermorelin uses the first 29 amino acids and lacks that added change.
Tesamorelin went through large FDA studies for one fat problem tied to HIV. Sermorelin has its own older history. The drugs haven't been tested against each other, so these studies can't tell you which works better or is safer.
How are the two drugs built differently?
Tesamorelin copies the whole brain hormone as a 44-amino-acid medicine. Amino acids are small protein parts. Sermorelin keeps only the first 29 amino acids. That shorter part can still ask the growth gland to release hormone.
There is another clear difference. Scientists changed the first part of tesamorelin so the body's protein-cutting chemicals work more slowly. Sermorelin has no such change. One drug is longer and slower to break apart; the other is shorter and breaks apart sooner.
Three facts give you a fair comparison. One drug has 44 amino acids; the other has 29. Only tesamorelin has the added first part, so their breakdown speeds differ. Those facts describe the drugs' makeup. They don't show which drug brings a better health result.
Why does the body break tesamorelin down more slowly?
The body's protein-cutting chemicals take the natural brain hormone apart within minutes. Tesamorelin has a changed first part that slows this cutting. The drug therefore gets more time to reach the growth gland.
After two weeks, healthy men's growth glands released more hormone in bursts [6]. That result shows tesamorelin gave its intended order in people. It doesn't show whether the change was helpful or safe for those men.
The study doesn't prove tesamorelin beats sermorelin. No trial has compared the drugs in matched groups. Saying one works better would go beyond the published proof.
Only the makeup is settled: tesamorelin is longer and slower to break down. Sermorelin is shorter and lacks the added first part.
What do human studies settle about tesamorelin?
Tesamorelin has several human studies. Two Phase 3 trials were large checks before approval for adults who had HIV and unusual belly fat [1][2]. An earlier test compared more than one amount [7]. Other work measured liver fat [3], time in blood, and the later hormone response [8][9]. A 2026 review combined five trials that had comparison groups [12].
The FDA approved tesamorelin in 2010, only for extra belly fat caused by unusual fat storage among adults who have HIV [5]. Sermorelin has a separate, older record that isn't reviewed here.
That narrow approval affects your choice. Doctors call every other tesamorelin use off-label because the FDA hasn't cleared it [5]. Drugs that act alike don't share proof or approval automatically.
A 2026 paper tested urine for both drugs [13]. The paper showed only how sports checks can find them; it said nothing about which drug is safer or more useful. Tesamorelin is banned in tested sport.